Last reviewed · How we verify
Placebo to match amlodipine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match amlodipine (Placebo to match amlodipine) — Organon and Co. This is an inert placebo formulation designed to match the appearance and administration of amlodipine for use in blinded clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match amlodipine TARGET | Placebo to match amlodipine | Organon and Co | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match amlodipine CI watch — RSS
- Placebo to match amlodipine CI watch — Atom
- Placebo to match amlodipine CI watch — JSON
- Placebo to match amlodipine alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match amlodipine — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-amlodipine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab